Interestingly, the levels of soluble CD157 correlated with human monocyte-derived macrophage bactericidal activity and exogenous administration of this form restored the bactericidal capacity of CD157-deficient macrophages, which raises the possibility that soluble CD157 might have a potential use in host-directed therapy against tuberculosis. The gene discussed is BST1; the disease is tuberculosis.